210 related articles for article (PubMed ID: 37686802)
1. Polyphenols' Impact on Selected Biomarkers of Brain Aging in Healthy Middle-Aged and Elderly Subjects: A Review of Clinical Trials.
Ziegler T; Tsiountsioura M; Meixner-Goetz L; Cvirn G; Lamprecht M
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686802
[TBL] [Abstract][Full Text] [Related]
2. Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain.
De Nicoló S; Tarani L; Ceccanti M; Maldini M; Natella F; Vania A; Chaldakov GN; Fiore M
Nutrition; 2013 Apr; 29(4):681-7. PubMed ID: 23466052
[TBL] [Abstract][Full Text] [Related]
3. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of neural activity, β-amyloid, and tau in normal brain aging.
Zhang K; Mizuma H; Zhang X; Takahashi K; Jin C; Song F; Gao Y; Kanayama Y; Wu Y; Li Y; Ma L; Tian M; Zhang H; Watanabe Y
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3859-3871. PubMed ID: 33674892
[TBL] [Abstract][Full Text] [Related]
5. Genetic epistasis regulates amyloid deposition in resilient aging.
Felsky D; Xu J; Chibnik LB; Schneider JA; Knight J; Kennedy JL; ; Bennett DA; De Jager PL; Voineskos AN
Alzheimers Dement; 2017 Oct; 13(10):1107-1116. PubMed ID: 28322202
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
[TBL] [Abstract][Full Text] [Related]
7. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer's Disease.
Girotra P; Behl T; Sehgal A; Singh S; Bungau S
J Mol Neurosci; 2022 Feb; 72(2):173-186. PubMed ID: 34424488
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
[TBL] [Abstract][Full Text] [Related]
10. NGF but not BDNF overexpression protects hippocampal LTP from beta-amyloid-induced impairment.
Ivanov AD; Tukhbatova GR; Salozhin SV; Markevich VA
Neuroscience; 2015 Mar; 289():114-22. PubMed ID: 25595986
[TBL] [Abstract][Full Text] [Related]
11. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
12. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
15. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
16. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
17. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
18. Relationships between biomarkers in aging and dementia.
Jagust WJ; Landau SM; Shaw LM; Trojanowski JQ; Koeppe RA; Reiman EM; Foster NL; Petersen RC; Weiner MW; Price JC; Mathis CA;
Neurology; 2009 Oct; 73(15):1193-9. PubMed ID: 19822868
[TBL] [Abstract][Full Text] [Related]
19. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
[TBL] [Abstract][Full Text] [Related]
20. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
